Mineral Resources’ AUD 180 million fiscal 2013 net profit comfortably exceeded analyst’s AUD 141 million forecast. Despite a 26% fall in headline profit, versus fiscal 2012, underlying profit increased 11% and marks an impressive seventh consecutive year of profit growth since the company listed in 2006. However, we maintain our thesis that inadequate operational and…
On Jan. 20, American Airlines Group Inc. (NASDAQ:AAL) promoted Vasu Raja to vice president – International Revenue Management. In this new role, Raja will lead a high-performing team responsible for overseeing all revenue generated from the company’s international business. American Airlines Group Inc. (NASDAQ:AAL) belongs to Services sector. Its net profit margin is 0.70% and…
Martin Midstream Partners L.P. (NASDAQ:MMLP) has earned a consensus recommendation of “Hold” from the seven analysts that are currently covering the company, Analyst Ratings Net reports. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Martin Midstream Partners LP (NASDAQ:MMLP) belongs to Basic…
Goldcorp Inc. (NYSE:GG) has announced that one of its subsidiaries has inked an agreement for selling its 100% interest in Wharf Mine at Lead, SD, to Coeur Mining, Inc. (CDE). Goldcorp will receive $105 million in cash from the sale, subject to specific closing adjustments. Goldcorp Inc. (NYSE:GG) belongs to Basic Materials sector. Its net…
The Supreme Court on Monday asked the U.S. government to weigh in on whether the justices should hear a closely watched copyright dispute between Google Inc and Oracle Corporation (NYSE:ORCL)over software used to design Google’s Android smartphone operating system. Oracle Corporation (NYSE:ORCL) belongs to Technology sector. Its net profit margin is 28.10% and weekly performance…
Macrophage Therapeutics, a newly created business unit of Navidea Biopharmaceuticals, Inc. (NYSE:NAVB), hosted a conference where data was presented using Manocept™ platform compound, tilmanocept, that was generated by independent academic collaborators with expertise in the HIV/AIDS, cancer, tuberculosis (TB), rheumatoid arthritis and cardiovascular disease therapeutic areas. Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB) belongs to Healthcare sector. Its…
